SpineGuard has secured $6.2 million to further extend its PediGuard platform for enhanced spinal screw placement. The company launched PediGuard Curv earlier this year and is preparing for the limited release of its Cannulated PediGuard, a "smart needle" to address minimally invasive spine surgery. Investors included Credit Agricole Private Equity, Innoven Partenaires, A Plus Finance, and Delta Partners.
"We are grateful for the continuing support from our four investors. New-product development is a cornerstone of our strategy to entrench the PediGuard family of products as a 'must-have' solution to the well-documented and universal clinical need for safer pedicle screw placement--the number one challenge in spine surgery." said Pierre Jerome, CEO of SpineGuard.